STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision - Seite 2

Corneal laser-based refractive procedures, like LASIK and SMILE, work by removing corneal tissue to thin and reshape the cornea to correct a patient’s vision. EVO ICL is a lens-based refractive procedure, which works by implanting a lens in the eye to correct a patient’s vision while preserving the cornea. Both lens and laser-based methods are safe and effective and have their place in a comprehensive refractive offering. EVO delivers excellent visual results across a broad range of correction with built-in UV protection and proven long-term stability. Further, EVO is a reversible lens implant, allowing surgeons to future-proof a patient’s eyes if age-related vision correction is needed down the road.

“At the IQ Laser Vision Family of Practices, our mission has always been to transform lives by delivering clear vision, and we are extremely grateful to have helped many patients including our own family members, celebrities, and athletes achieve that transformation,” said Robert T. Lin, MD, founder and surgeon, IQ Laser Vision. “Refractive practices are at a critical juncture – with interest in corneal-based laser procedures waning, and contact lens- and eyeglass-wearers reluctant to commit to a more permanent solution – it’s time to consider a new path forward.”

Dr. Lin continued, “While studies show that refractive vision correction may be safer than long-term use of contact lenses, patients have been shying away from corneal-based laser vision correction (such as LASIK) due to a variety of factors. I believe EVO ICL is a way to re-invigorate the refractive surgery category as a whole. With surgeons across Europe and Asia using EVO ICL across the diopter range, and many offering ICL as the first-line treatment, it’s clear to me that we need to get the word out in the U.S. I am grateful to STAAR for recognizing this immense need, and working with us as we help patients achieve their dream of visual freedom.”

For more information about EVO Implantable Collamer Lenses, please visit https://evoicl.com.

References

1. EVO/EVO+ ICL DFU and PIB.
2. Martinez-Plaza E, Lopez-Miguel A, Lopez-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117–125.
3. Naves, J. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

About STAAR Surgical